Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 3
1989 2
1990 7
1991 9
1992 11
1993 23
1994 18
1995 22
1996 65
1997 72
1998 100
1999 116
2000 125
2001 107
2002 144
2003 139
2004 175
2005 216
2006 185
2007 206
2008 221
2009 254
2010 223
2011 263
2012 247
2013 213
2014 199
2015 178
2016 153
2017 170
2018 146
2019 82
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

3,660 results
Results by year
Filters applied: . Clear all
Page 1
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.
Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A. Saag KG, et al. N Engl J Med. 2017 Oct 12;377(15):1417-1427. doi: 10.1056/NEJMoa1708322. Epub 2017 Sep 11. N Engl J Med. 2017. PMID: 28892457 Free article. Clinical Trial.
Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate.
Asadipooya K, Weinstock A. Asadipooya K, et al. Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1343-1350. doi: 10.1161/ATVBAHA.119.312371. Epub 2019 May 23. Arterioscler Thromb Vasc Biol. 2019. PMID: 31242037 Review.
Hip fracture risk and safety with alendronate treatment in the oldest-old.
Axelsson KF, Wallander M, Johansson H, Lundh D, Lorentzon M. Axelsson KF, et al. J Intern Med. 2017 Dec;282(6):546-559. doi: 10.1111/joim.12678. Epub 2017 Oct 4. J Intern Med. 2017. PMID: 28857352 Free article. Clinical Trial.
3,660 results
Jump to page
Feedback